// App-Quantinova.ai

: Sarcoidosis treatment and outcomes: what is most important to patients?

Researchers

Presenter

  • Jeanette Boyd

Principal Investigators

  • Robert P. Baughman

  • Dominique Valeyere

  • Ana Rosa lvarez Rodrguez

  • Linda Charvoz

  • Hanns-Peter Faber

  • Chris Knoet

  • Filippo Martone

  • Dorrit Irne Novel

  • Bernd Quadder

  • Jack Richardson

  • Ginger Spitzer

  • Gianluca Ziosi

  • Johanna Hochreiter

Medical Centers

  • European Lung FOundation, London, United Kingdom

  • Paris, France

  • Asociación Nacional de Enfermos de Sarcoidosis (ANES), Santander, Spain

  • Schweizerische Sarkoidose-Vereinigung (SSARV) and University of Applied Sciences and Arts Western Switzerland, Lausanne, Switzerland

  • EPOS (European association of patients organisations of sarcoidosis), Meerbusch , Germany

  • Sarcoidose Belangenvereniging Nederland, The Hague, Netherlands

  • Amici Contro La Sarcoidosi Italia onlus, Bologna, Italy

  • Schweizerische Sarkoidose-Vereinigung (SSARV) Association Suisse contre la Sarcoïdose (AScS), Yverdon-les-Bains, Switzerland

  • Deutsche Sarkoidose-Vereinigung (DSV), Meerbusch, Germany

  • SarcoidosisUK, London, United Kingdom

  • Foundation for Sarcoidosis Research, Chicago, United States of America

  • Lungenfibrose Forum Austri, Neulengbach, Austria

Locations

  • United Kingdom

  • United States

  • France

  • Spain

  • Switzerland

  • Germany

  • Netherlands

  • Italy

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Sarcoidosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved